Add Company
Join Now

Speranza Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Speranza Therapeutics's estimated annual revenue is currently $3.1M per year.(i)
  • Speranza Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Speranza Therapeutics has 20 Employees.(i)
  • Speranza Therapeutics grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Speranza Therapeutics?

Speranza Therapeutics distributes and clinically supports orphan drugs and medical devices, creating options for patients whose chronic illnesses are not being effectively addressed. Our guiding principle is simple - To remove the inherent challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology. S.T. Genesisâ„¢ is the first Speranza Therapeutics Innovation to hit the market. S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS), used as an aid to reduce the symptoms of opioid withdrawal. This powerful solution to the opioid crisis will partner with treatment centers, providing them with leading clinical technology, comprehensive protocols, patient support, and reimbursement services. To learn more about Speranza Therapeutics and our products, please visit our website: http://speranzatherapeutics.com/

keywords:N/A

N/A

Total Funding

20

Number of Employees

$3.1M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M20N/AN/A
#2
N/A2025%$37M
#3
$1.7M20-17%N/A
#4
$4.3M20-23%N/A
#5
$2.9M20-23%N/A